维普期刊资源整合服务平台（V6.5）

607篇 您的检索式：期刊名="PharmacoEconomics"

选中清除导出查看参考文献查看引证文献引用追踪共31页首页上一页第1页下一页末页 /31 跳转

	题名	作者	年代	出处	被引量
1	A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis显示文摘	Christopher Fitzpatrick Katherine Floyd	2012	PharmacoEconomics2012，，1：	2
2	Use of Proton Pump Inhibitors for the Provision of Stress Ulcer Prophylaxis: Clinical and Economic Consequences显示文摘	Jeffrey F. Barletta David A. Sclar	2014	PharmacoEconomics2014，，1：	2
3	Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy显示文摘	Burchardi H Schneider H	2004	Pharmacoeconomics2004，22，：	1
4	Economic evaluation of influenza vaccination: assessment for the Netherlands显示文摘	Bos MJ Gennep M	1999	Pharmacoeconomics1999，16，1：	1
5	The Distribution of Sales Revenues from Pharmaceutical Innovation显示文摘	Grabowski HG Vernon J	2000	Pharmacoeconomics2000，18，1：	1
6	Economic evaluation of vaccination programmes:a consensus statement focusing on viralhepatitis显示文摘	Beutels P Edmunds WJ Antoanzas F	2002	Pharmacoeconomics2002，20，1：	1
7	What Works and What Doesn' t Work Well in the US Healthcare System显示文摘	Luft Harold S	2006	PharmacoEconomics2006，24，9：	1
8	Unrelated medi- cal costs in life-years gained 显示文摘	DAVID R R PIETER H M B JOB A E	2008	Pharmacoeconomics2008，26，10：	1
9	The burden of schizophrenia on caregivers : a review显示文摘	Awad G Voruganti P	2008	Pharmacoeconomics2008，26，2：	1
10	Willingness to pay for inhaled insulin :a contingent valuation approach显示文摘	Sadri H MacKeigan LD Leiter LA	2005	Pharmacoeconomics2005，23，12：	1
11	Cost of lung canc- er: a methodological review 显示文摘	Molinier L Combescure C Chouaid C	2006	Pharmacoeconomics2006，24，7：	1
12	The humanistic and economic burden of systemic lupus erythematosus: a systematic review显示文摘	Meacock R Dale N Harrison MJ	2013	Pharmacoeconomics2013，31，1：	1
13	Economic evaluations of influenza vaccination in healthy working-age adults:Employer and society perspective显示文摘		2000	Pharmacoeconomics2000，18，2：	1
14	An introduction to Markov modelling for economic evaluation显示文摘	BRIGGS A SCULPHER M	1998	Pharmacoeconomics1998，13，4：	1
15	Methods for Measuring Temporary Health States for Cost-Utility Analyses显示文摘	Wright D R Wittenberg E Swan J S Miksad RA Prosser LA	2009	Pharmacoeconomics2009，27，9：	1
16	Creative compliance in pharmac- eutical markets: the case of profit controls显示文摘	Bradley J Vandoros S	2012	Expert Re- view of Pharmacoeconomics & Outcomes Research2012，12，1：	1
17	The burden of migra- tion in the united states:current and emerging perspectives on disease management and economic analysis显示文摘	Elisabeth H Julie M Bigal ME	2008	Int Socie- ty Pharmacoeconomics Outcomes Researeh(ISPOR)2008，9，10983015：	1
18	Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis: an application of Bayesian methods for evidence synthesis in a Markov model 显示文摘	NGUYEN CM BOUNTHAVONG M MENDES MA	2012	Pharmacoeconomics2012，30，7：	1
19	The future of health technology assessment in health- care decision making in Asia 显示文摘	YANG BM	2009	Pharmacoeconomics2009，27，11：	1
20	A pharmacoeconomic model for the treatment of influenza显示文摘	Cates CS Griffin DA	1999	Pharmacoeconomics1999，16，1：	1

返回顶部每页显示：

共31页首页上一页第1页下一页末页 /31 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示